SQ Innovation
@sqinnovation.com
Novel options for treatment of fluid overload in heart failure. Our combination product Lasix ONYU received Tentative Approval from the US FDA in 2024. See www.sqinnovation.com for additional information.
www.usnews.com
October 10, 2025 at 7:59 PM
Treating worsening heart failure at home instead of at a hospital is a big deal enabled by a small device. The tradename is "Fusiq" outside the US and "Lasix ONYU" in the US. #heartfailure #furosemide
March 18, 2025 at 3:00 PM
Treating worsening heart failure at home instead of at a hospital is a big deal enabled by a small device. The tradename is "Fusiq" outside the US and "Lasix ONYU" in the US. #heartfailure #furosemide
This week we filed for MDR Conformity Assessment better known as CE marking for our furosemide Infusor. This is the first of a two-step process for marketing authorization of our furosemide Infusor under the tradename Fusiq. #furosemide #heartfailure
March 18, 2025 at 10:42 AM
This week we filed for MDR Conformity Assessment better known as CE marking for our furosemide Infusor. This is the first of a two-step process for marketing authorization of our furosemide Infusor under the tradename Fusiq. #furosemide #heartfailure